Among the clinical presentations featuring data about Edwards' devices
Sunday, May 11
-- Session V, Percutaneous Aortic Valve Replacement: Update on
Percutaneous AVR with Edwards SAPIEN Valve (retrograde and antegrade)
-- 4:15 p.m. to 4:35 p.m. Ballroom 20 A-C, San Diego Convention
Center. Presenter: John G. Webb, St. Paul's Hospital, Vancouver, BC,
-- Session V, Percutaneous Aortic Valve Replacement: Identification of
Appropriate Patients: Who Actually is "Inoperable"? -- 4:55 p.m. to
5:15 p.m. Ballroom 20 A-C, San Diego Convention Center. Presenter:
Michael J. Mack, Cardiothoracic Surgery Associates of North Texas,
Wednesday, May 14
-- Emerging Technologies and Techniques Forum: Is Transcatheter Based
Aortic Valve Implantation Really Less Invasive than Minimal Invasive
Aortic Valve Replacement? -- 7:13 a.m. to 7:26 a.m. Room 25, San Diego
Convention Center. Presenters/authors: Mirko Doss, Sven Martens,
Stephan Fichtelscherer, Thomas Trepels, Gerhard Wimmer Greinecker,
Anton Moritz, Volker Schachinger, Thoracic and Cardiovascular Surgery,
J.W. Goethe University Frankfurt, Frankfurt am Main, Germany.
-- Emerging Technologies and Techniques Forum: Transapical Transcatheter
Aortic Valve Implantation One Year Follow-Up in 19 Patients --
8:05 a.m. to 8:18 a.m. Room 25, San Diego Convention Center.
Presenters/authors: Jian Ye, Anson Cheung, John G. Webb, Daniel R.
Wong, Ronald G. Carere, Christopher R. Thompson, Samuel V.
Lichtenstein, Cardiothoracic Surgery, University of British Columbia,
|SOURCE Edwards Lifesciences Corporation|
Copyright©2008 PR Newswire.
All rights reserved